Biohaven (BHVN) Operating Expenses (2021 - 2026)

Biohaven has disclosed Operating Expenses across 6 years of filings, most recently posting $130.4 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $130.4 million, down 41.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $654.2 million (down 29.15% YoY), and the FY2025 annual result was $745.4 million, down 15.79% from the prior year.
• Operating Expenses came in at $130.4 million for Q1 2026 at Biohaven, down from $142.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $333.8 million in Q2 2024 to a low of $67.6 million in Q3 2022.
• The 5-year median for Operating Expenses is $169.4 million (2025), against an average of $162.6 million.
• Across the five-year window, Operating Expenses surged 319.42% in 2022 and plunged 52.31% in 2023, its largest moves.
• Biohaven's Operating Expenses stood at $213.4 million in 2022, then retreated by 27.97% to $153.7 million in 2023, then grew by 23.56% to $189.9 million in 2024, then decreased by 24.85% to $142.7 million in 2025, then declined by 8.62% to $130.4 million in 2026.
• The last three Operating Expenses figures came in at $130.4 million (Q1 2026), $142.7 million (Q4 2025), and $169.4 million (Q3 2025), per Business Quant data.